Microbiome and Liver Health
Recent advancements in microbiome research have unveiled profound implications for liver health. The intricate interplay between gut microbiota and liver function is increasingly recognized as pivotal in both health and disease. This track at GASTROENTEROLOGY-2024 aims to explore the latest findings in microbiome science as it relates to liver diseases, spanning from non-alcoholic fatty liver disease (NAFLD) to cirrhosis and hepatocellular carcinoma.
Key Topics:
- Microbiota Composition and Liver Diseases: Insights into how gut microbial communities influence liver pathology.
- Therapeutic Interventions: Novel microbiome-based approaches for managing liver disorders.
- Role of Diet and Lifestyle: Impact of dietary habits and lifestyle on microbiome composition and liver health.
- Technological Advances: Cutting-edge methodologies in microbiome research and their application in liver disease.
Attendees Can Expect: Attendees will gain comprehensive insights into the latest research linking microbiome dynamics with liver health. From mechanistic understandings to clinical implications, this track promises to illuminate new avenues for therapeutic strategies and public health interventions aimed at optimizing liver function through microbiome modulation.
Related Conference of Microbiome and Liver Health
25th International Conference on Gastroenterology and Digestive Disorders
Microbiome and Liver Health Conference Speakers
Recommended Sessions
- Artificial Intelligence and Digital Health in Gastroenterology
- Bariatric and Metabolic Surgery
- Biomarkers for Gastrointestinal Diseases
- Colorectal Cancer Screening and Surveillance
- Endoscopic Innovations in Gastrointestinal Disorders
- Functional Gastrointestinal Disorders (FGIDs)
- Gastrointestinal Motility Disorders
- Gastrointestinal Oncology
- Gut Microbiota and Digestive Health
- Hepatitis B and Hepatitis C
- Hepatocellular Carcinoma (HCC)
- Liver Fibrosis and Cirrhosis
- Liver Transplantation and Regenerative Medicine
- Microbiome and Liver Health
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
- Nutrition and Digestive Health
- Pediatric Gastroenterology
- Precision Medicine in Gastrointestinal Cancers
- Quality Improvement and Patient-Centered Care
- Therapeutic Advances in Inflammatory Bowel Disease (IBD)
Related Journals
Are you interested in
- Advances in Medical Imaging - Gastrosummit 2027 (France)
- Celiac Disease - Gastrosummit 2027 (France)
- Colorectal Diseases - Gastrosummit 2027 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - Gastrosummit 2027 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Esophageal Disorders - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastric Diseases and Peptic Ulcers - Gastrosummit 2027 (France)
- Gastrointestinal Bleeding - Gastrosummit 2027 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Pharmacology - Gastrosummit 2027 (France)
- Gastrointestinal Surgery - Gastrosummit 2027 (France)
- Geriatric Gastroenterology - Gastrosummit 2027 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2027 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastrosummit 2027 (France)
- Liver Transplantation - Gastrosummit 2027 (France)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Nutrition in Digestive Health - Gastrosummit 2027 (France)
- Pancreatic Diseases - Gastrosummit 2027 (France)
- Pancreaticobiliary Disorders - Gastrosummit 2027 (France)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology - Gastrosummit 2027 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Precision Medicine in Digestive Diseases - Gastrosummit 2027 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Viral Hepatitis - Gastrosummit 2027 (France)
